Our Mission

Cytovance Biologics' mission is to become a value-added partner to our clients by providing an integral pathway in converting today's novel protein discoveries into future life saving therapies and diagnostics. 

Cytovance Biologics is your partner in biopharmaceutical contract manufacturing of therapeutic proteins and antibodies from mammalian cell culture and microbial fermentation.

Latest News

Cytovance Biologics and Selexys Pharmaceuticals Announce Development and cGMP Manufacturing Agreement

Cytovance Biologics announces a development and manufacturing agreement with Selexys Pharmaceuticals of SELK2, directed toward the treatment of Crohn’s Disease and Multiple Myeloma.
 

Cytovance Biologics and Precision Biologics Announce Extended cGMP Manufacturing Agreement

Cytovance Biologics extends its manufacturing agreement with Precision Biologics, Inc. of its leading monoclonal antibody candidate - NEO-102, a therapeutic for pancreatic and colorectal cancers.
 


>> READ MORE CYTOVANCE NEWS

 

 

Careers

cGMP Manufacturing Careers at Cytovance Biologics
 

We are searching for talented life science professionals to join the Cytovance team.
 

>> SEE ALL CYTOVANCE JOB OPENINGS

 

 

Conferences

Contracting and Outsourcing Conference in New Brunswick, NJ
September 18-19, 2014


CPhI Worldwide, Paris, France
October 7-9, 2014


BioProcess International, Boston, MA
October 20-23, 2014


>> READ FULL EVENT CALENDAR